Your Search for 'Tobacco Products - Russia - a snapshot (2011)' returned 6 results - Page 1 of 1

• Cigarettes - Global Strategic Business Report

  EURO€ 3,982.00USD$ 4,500.00GBP£ 2,655.00AUD$ 6,223.00JPY¥ 539,634.00SEK 35 400,00CHF 5'926.00CAD$ 5,772.00 Global Industry Analysts, Inc, Feb 2013 , Pages: 463
  Cigarette Market (2011): Percentage Breakdown of Volume Sales for Philip Morris International, British American Tobacco, Japan Tobacco, Imperial Tobacco and Others (includes corresponding Graph/Chart) II ...

• Croatia Retail Report Q4 2011

  EURO€ 874.00USD$ 1,137.00GBP£ 735.00AUD$ 1,112.00JPY¥ 112,215.00SEK 7 462,00CHF 1'071.00CAD$ 1,158.00 Business Monitor International, Sep 2011 , Pages: 59
  prices offered by foreign and domestic chains, easier access to credit and anticipated EU accession. Croatia’s nominal GDP in 2011 is predicted to be US$63.2bn, with growth of 1.7% forecast for the year ...

• Croatia Retail Report Q3 2011

  EURO€ 874.00USD$ 1,137.00GBP£ 735.00AUD$ 1,112.00JPY¥ 112,215.00SEK 7 462,00CHF 1'071.00CAD$ 1,158.00 Business Monitor International, May 2011 , Pages: 55
  products both increase. BMI data suggest that OTC pharmaceutical sales will amount to US$0.11bn in 2011 and we forecast an increase of 17% to US$0.13bn by 2015. The automotives sector is also predicted to ...

• Diabetes - Pipeline Review, Q1 2011

  EURO€ 384.00USD$ 500.00GBP£ 323.00AUD$ 489.00JPY¥ 49,366.00SEK 3 283,00CHF 471.00CAD$ 509.00 Global Markets Direct, Mar 2011 , Pages: 393
  Disclaimer List of Tables Number of Products Under Development for Diabetes, Q1 2011 Products under Development for Diabetes – Comparative Analysis, Q1 2011 Comparative Analysis by Late Stage ...

• Croatia Retail Report Q1 2011

  EURO€ 874.00USD$ 1,137.00GBP£ 735.00AUD$ 1,112.00JPY¥ 112,215.00SEK 7 462,00CHF 1'071.00CAD$ 1,158.00 Business Monitor International, Nov 2010 , Pages: 57
  demand for pharmaceutical products both increase. BMI data suggest that OTC pharmaceutical sales will amount to US$0.11bn in 2011, and we forecast an increase of more than 12% to US$0.13bn by 2014 ...

• Pharmaceutical Anti-Counterfeiting. Combating the Real Danger from Fake Drugs

  EURO€ 72.00USD$ 94.00GBP£ 60.00AUD$ 92.00JPY¥ 9,237.00SEK 614,00CHF 88.00CAD$ 95.00 John Wiley and Sons Ltd, Aug 2011 , Pages: 426
  3 A Snapshot of the Problem 15 Case Study: Malaria 18 4 Risks and Costs of Counterfeit Pharmaceuticals 21 Risks and Costs for Consumers 21 The Drugs Do Not Work 21 Toxic Products 23 ...